학술논문

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
Document Type
article
Author
Telomeres Mendelian Randomization CollaborationHaycock, Philip CBurgess, StephenNounu, AayahZheng, JieOkoli, George NBowden, JackWade, Kaitlin HazelTimpson, Nicholas JEvans, David MWilleit, PeterAviv, AbrahamGaunt, Tom RHemani, GibranMangino, MassimoEllis, Hayley PatriciaKurian, Kathreena MPooley, Karen AEeles, Rosalind ALee, Jeffrey EFang, ShenyingChen, Wei VLaw, Matthew HBowdler, Lisa MIles, Mark MYang, QiongWorrall, Bradford BMarkus, Hugh StephenHung, Rayjean JAmos, Chris ISpurdle, Amanda BThompson, Deborah JO'Mara, Tracy AWolpin, BrianAmundadottir, LaufeyStolzenberg-Solomon, RachaelTrichopoulou, AntoniaOnland-Moret, N CharlotteLund, EilivDuell, Eric JCanzian, FedericoSeveri, GianlucaOvervad, KimGunter, Marc JTumino, RosarioSvenson, Ulrikavan Rij, AndreBaas, Annette FBown, Matthew JSamani, Nilesh Jvan t'Hof, Femke NGTromp, GerardJones, Gregory TKuivaniemi, HelenaElmore, James RJohansson, MattiasMckay, JamesScelo, GhislaineCarreras-Torres, RobertGaborieau, ValerieBrennan, PaulBracci, Paige MNeale, Rachel EOlson, Sara HGallinger, StevenLi, DonghuiPetersen, Gloria MRisch, Harvey AKlein, Alison PHan, JialiAbnet, Christian CFreedman, Neal DTaylor, Philip RMaris, John MAben, Katja KKiemeney, Lambertus AVermeulen, Sita HWiencke, John KWalsh, Kyle MWrensch, MargaretRice, TerriTurnbull, ClareLitchfield, KevinPaternoster, LaviniaStandl, MarieAbecasis, Gonçalo RSanGiovanni, John PaulLi, YongMijatovic, VladanSapkota, YadavLow, Siew-KeeZondervan, Krina TMontgomery, Grant WNyholt, Dale Rvan Heel, David AHunt, KarenArking, Dan EAshar, Foram NSotoodehnia, NonaWoo, Daniel
Source
JAMA oncology. 3(5)
Subject
Telomeres Mendelian Randomization Collaboration
Telomere
Humans
Neoplasms
Cardiovascular Diseases
Genetic Predisposition to Disease
Risk Assessment
Germ-Line Mutation
Polymorphism
Single Nucleotide
Adult
Aged
Aged
80 and over
Middle Aged
Female
Male
Genome-Wide Association Study
Mendelian Randomization Analysis
Telomere Homeostasis
Polymorphism
Single Nucleotide
and over
Prevention
Clinical Research
Cancer
Genetics
Rare Diseases
2.1 Biological and endogenous factors
Oncology and Carcinogenesis
Public Health and Health Services
Language
Abstract
ImportanceThe causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation.ObjectiveTo conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases.Data sourcesGenomewide association studies (GWAS) published up to January 15, 2015.Study selectionGWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available.Data extraction and synthesisSummary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population.Main outcomes and measuresOdds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation.ResultsSummary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]).Conclusions and relevanceIt is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.